found that hs-CRP increases the risk of CVD for MHO participants with hs-CRP ≥ 2 mg/L than metabolically healthy participants with hs-CRP < 2 mg/L (p = 0.066; HR = 1.59; 95% CI HR = 0.97/2.62), although this trend did not reach statistical significance. hs-CRP appears to be an easy and widely available molecule for identifying a low-risk subpopulation among metabolically healthy obese persons [ 34 ].
← all excerpts
Metabolically healthy obese individuals present similar chronic inflammation level but less insulin-resistance than obese individuals with metabolic syndrome.
1
—
—